Literature DB >> 7296786

Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.

M Tada, T Kuzuya, M Inoue, K Kodama, M Mishima, M Yamada, M Inui, H Abe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296786     DOI: 10.1161/01.cir.64.6.1107

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

Review 1.  The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury.

Authors:  J L Mehta; W W Nichols
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

2.  Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.

Authors:  A Maassen VanDenBrink; W A Bax; M D Ferrari; F J Zijlstra; E Bos; P R Saxena
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Dazoxiben: a pharmacological tool or clinical candidate?

Authors:  H M Tyler
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  [Thromboxane concentrations in the arterial blood of cigarette smokers].

Authors:  F J Krause
Journal:  Klin Wochenschr       Date:  1986-07-15

5.  Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.

Authors:  N Toda
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

6.  Coronary artery vasospasm complicating acute myocarditis. A rare association.

Authors:  D W Ferguson; A P Farwell; W A Bradley; R C Rollings
Journal:  West J Med       Date:  1988-06

7.  Regional differences in the response to vasoconstrictor agents of dog and monkey isolated coronary arteries.

Authors:  K Miwa; N Toda
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

Review 8.  Serotonin and the vascular system. Role in health and disease, and implications for therapy.

Authors:  D S Houston; P M Vanhoutte
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

9.  Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.

Authors:  P S Kiff; G Bergman; L Atkinson; D E Jewitt; J Westwick; V V Kakkar
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.

Authors:  I Hutton; A C Tweddel; A C Rankin; I D Walker; J F Davidson
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.